Identification of diverse innate lymphoid cells in human decidua

Mucosal Immunology

Volumn 8, Issue 2, 2015, Pages 254-264

  Vacca, P ^a   Montaldo, E ^a,b   Croxatto, D ^a,b   Loiacono, F ^b,c   Canegallo, F ^c   Venturini, P L ^a,b   Moretta, L ^c   Mingari, M C ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 8; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; VASCULAR CELL ADHESION MOLECULE 1; CYTOKINE; MEMBRANE ANTIGEN;

ARTICLE; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DECIDUA; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INNATE IMMUNITY; LYMPHOID CELL; PHENOTYPE; PROTEIN EXPRESSION; UPREGULATION; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; FEMALE; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; METABOLISM; NATURAL KILLER CELL; PREGNANCY;

ANTIGENS, SURFACE; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; DECIDUA; FEMALE; HUMANS; IMMUNITY, INNATE; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; LYMPHOCYTES; PHENOTYPE; PREGNANCY;

EID: 84922722546     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2014.63     Document Type: Article

References (50)

1. Spits, H., et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145-149 (2013).
2. Spits, H. & Cupedo, T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Ann. Rev. Immunol. 30, 647-675 (2012).
3. Trinchieri, G. Biology of natural killer cells. Adv. Immunol. 47, 187-376 (1989).
4. Caligiuri, M.A. Human natural killer cells. Blood 112, 461-469 (2008).
5. Moretta, A., et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Ann. rev. immunol. 19, 197-223 (2001).
6. Moretta, L. & Moretta, A. Killer immunoglobulin-like receptors. Curr. Opin. Immunol. 16, 626-633 (2004).
7. Pende, D., et al. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med. 190, 1505-1516 (1999).
8. Sivori, S., et al. p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J. Exp. Med. 186, 1129-1136 (1997).
9. Vitale, M., et al. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 187, 2065-2072 (1998).
10. Kamizono, S., et al. Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo. J. Exp. Med. 206, 2977-2986 (2009).
11. Yokota, Y., et al. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397, 702-706 (1999).
12. Boos, M.D., Yokota, Y., Eberl, G. & Kee, B.L. Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. J. Exp. Med. 204, 1119-1130 (2007).
13. Gascoyne, D.M., et al. The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nat. Immunol. 10, 1118-1124 (2009).
14. Aliahmad, P., de la Torre, B. & Kaye, J. Shared dependence on the DNAbinding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages. Nat. Immunol. 11, 945-952 (2010).
15. Gordon, S.M., et al. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 36, 55-67 (2012).
16. Luevano, M., Madrigal, A. & Saudemont, A. Transcription factors involved in the regulation of natural killer cell development and function: an update. Front. Immunol. 3, 319 (2012).
17. Bernink, J.H., et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat. Immunol. 14, 221-229 (2013).
18. Fuchs, A., et al. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells. Immunity 38, 769-781 (2013).
19. Mjosberg, J.M., et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat. Immunol. 12, 1055-1062 (2011).
20. Cherrier, M. & Eberl, G. The development of LTi cells. Curr. Opin. Immunol. 24, 178-183 (2012).
21. Crellin, N.K., Trifari, S., Kaplan, C.D., Cupedo, T. & Spits, H. Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells. J. Exp. Med. 207, 281-290 (2010).
22. Cella, M., et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457, 722-725 (2009).
23. Colonna, M. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 31, 15-23 (2009).
24. Cupedo, T., et al. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127(+) natural killer-like cells. Nat. Immunol. 10, 66-74 (2009).
25. Luci, C., et al. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat. Immunol. 10, 75-82 (2009).
26. Hanna, J., et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat. Med. 12, 1065-1074 (2006).
27. Le Bouteiller, P. & Tabiasco, J. Killers become builders during pregnancy. Nat. Med. 12, 991-992 (2006).
28. Saito, S., Nakashima, A., Shima, T. & Ito, M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am. J. Reprod. Immunol. 63, 601-610 (2010).
29. Moffett-King, A. Natural killer cells and pregnancy. Nat. Rev. Immunol. 2, 656-663 (2002).
30. Vacca, P., et al. CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells. Proc. Natl. Acad. Sci. USA 108, 2402-2407 (2011).
31. Male, V., Hughes, T., McClory, S., Colucci, F., Caligiuri, M.A. & Moffett, A. Immature NK cells, capable of producing IL-22, are present in human uterine mucosa. J. Immunol. 185, 3913-3918 (2010).
32. Carlino, C., et al. Recruitment of circulating NK cells through decidual tissues: a possible mechanism controlling NK cell accumulation in the uterus during early pregnancy. Blood 111, 3108-3115 (2008).
33. Kopcow, H.D., et al. Human decidual NK cells form immature activating synapses and are not cytotoxic. Proc. Natl. Acad. Sci. USA 102, 15563-15568 (2005).
34. Vacca, P., et al. Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function. Blood 108, 4078-4085 (2006).
35. Vacca, P., et al. Regulatory role of NKp44, NKp46, DNAM-1 and NKG2D receptors in the interaction between NK cells and trophoblast cells. Evidence for divergent functional profiles of decidual versus peripheral NK cells. Int. Immunol. 20, 1395-1405 (2008).
36. Vacca, P., Moretta, L., Moretta, A. & Mingari, M.C. Origin, phenotype and function of human natural killer cells in pregnancy. Trends Immunol. 32, 517-523 (2011).
37. Vacca, P., et al. Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression. Proc. Natl. Acad. Sci. USA 107, 11918-11923 (2010).
38. Glatzer, T., et al. RORgammat(+) innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44. Immunity 38, 1223-1235 (2013).
39. Montaldo, E., et al. HumanNK cells at early stages of differentiation produce CXCL8 and express CD161 molecule that functions as an activating receptor. Blood 119, 3987-3996 (2012).
40. Ahn, Y.O., Blazar, B.R., Miller, J.S. & Verneris, M.R. Lineage relationships of human interleukin-22-producing CD56+ RORgammat+ innate lymphoid cells and conventional natural killer cells. Blood 121, 2234-2243 (2013).
41. Cella, M., Otero, K. & Colonna, M. Expansion of human NK-22 cells with IL- 7, IL-2, and IL-1beta reveals intrinsic functional plasticity. Proc. Natl. Acad. Sci. USA 107, 10961-10966 (2010).
42. Freud, A.G., et al. Evidence for discrete stages of human natural killer cell differentiation in vivo. J. Exp. Med. 203, 1033-1043 (2006).
43. Freud, A.G., Yu, J. & Caligiuri, M.A. Human natural killer cell development in secondary lymphoid tissues. Semin. Immunol. 26, 132-137 (2014).
44. Spits, H. & Di Santo, J.P. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 12, 21-27 (2011).
45. Cella, M., et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457, 722-725 (2009).
46. Hanna, J. & Mandelboim, O. When killers become helpers. Trends Immunol. 28, 201-206 (2007).
47. Jessmon, P., Leach, R.E. & Armant, D.R. Diverse functions of HBEGF during pregnancy. Mol. Reprod. Dev. 76, 1116-1127 (2009).
48. Hughes, T., et al. Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue. Immunity 32, 803-814 (2010).
49. Hughes, T., et al. Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22. Blood 113, 4008-4010 (2009).
50. Croxatto, D., et al. Stromal cells from human decidua exert a strong inhibitory effect on NK cell function and dendritic cell differentiation. PloS ONE 9, e89006 (2014).